Jiayan Chen

Subscribe to Jiayan Chen's Posts
Jiayan Chen is deeply experienced in the regulatory, transactional and strategic issues that arise when leveraging health information, biospecimens and technology to drive healthcare innovation and quality. She guides stakeholders on privacy compliance and research compliance and in the context of strategic initiatives and collaborations as they seek to harness the power of data, machine learning, DNA sequencing and technologies to develop and deploy new products and solutions and address challenges in healthcare delivery and payment. Read Jiayan Chen's full bio.

FDA Establishes CDER Center for Drug Innovation (C3TI)


By , , , , and on May 29, 2024
Posted In Employee Benefits, Health and Welfare Plans

On April 15, 2024, the US Food & Drug Administration (FDA) announced the establishment of the Center for Drug Evaluation and Research (CDER) Center for Clinical Trial Innovation (C3TI). C3TI will serve as the central support hub for innovative approaches to clinical trials designed to improve the quality and efficiency of drug development and regulatory...

Continue Reading



OCR Issues Proposed Rule to Modify HIPAA Privacy Rule to Include Explicit Protections for Reproductive Healthcare


By , , , and on Apr 20, 2023
Posted In Digital Health, Employee Benefits, Health and Welfare Plans

On April 12, 2023, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued a notice of proposed rulemaking detailing its proposal to modify the HIPAA Privacy Rule (Proposed Rule). The Proposed Rule comes as a part of the Biden administration’s response to the US Supreme Court’s ruling in Dobbs v. Jackson Women’s...

Continue Reading



Artificial Intelligence Myth Versus Reality: Where Do Healthcare Experts Think We Stand?


By and on Nov 12, 2021
Posted In Digital Health, Employee Benefits, Health and Welfare Plans

As the healthcare industry evaluates how to pay for artificial intelligence (AI) solutions, industry experts say data and real-world evidence are essential for reaching any payment decisions. In this Forbes article, McDermott Partners Dale C. Van Demark and Jiayan Chen provide insight into some of the regulatory challenges AI presents. “For AI to be paid...

Continue Reading



Protecting the Telehealth Consumer: FTC and State-Based Considerations


By on Sep 21, 2021
Posted In Digital Health, Employee Benefits, Health and Welfare Plans, Privacy and Data Security

Telemedicine in the United States is facing an important crossroads. While telehealth services have demonstrated their value as an integral part of care delivery, federal and state waivers instituted during the COVID-19 pandemic are likely to expire soon. As lawmakers and agency officials consider updated or expanded digital health rules, regulators are expected to intensify...

Continue Reading



Digital Health Year in Review: 2017 Trends and Looking Ahead to 2018


By , , , , , , , , , and on Feb 8, 2018
Posted In Health and Welfare Plans, Privacy and Data Security

Throughout 2017, the health care and life sciences industries experienced a widespread proliferation of digital health innovation that presents challenges to traditional notions of health care delivery and payment as well as product research, development and commercialization for both long-standing and new stakeholders. At the same time, lawmakers and regulators made meaningful progress toward modernizing...

Continue Reading



STAY CONNECTED

TOPICS

ARCHIVES

Top ranked chambers 2022
US leading firm 2022